Championing Global Health: Walgreens Boots Alliance New

Total Page:16

File Type:pdf, Size:1020Kb

Championing Global Health: Walgreens Boots Alliance New Championing Global Health: Walgreens Boots Alliance New Global Sustainability Report Details Support for People Living with Cancer and Eorts to Improve Child and Maternal Health 2/11/2020 Company Continues Progress on Reducing Carbon Footprint LONDON--(BUSINESS WIRE)-- Walgreens Boots Alliance (Nasdaq: WBA) today announced the publication of its 2019 Corporate Social Responsibility (CSR) Report, which details the company’s global sustainability initiatives, including eorts to improve access to quality healthcare, deliver support programs for people living with cancer and reduce its carbon footprint. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200211005125/en/ Walgreens stores sponsored more than 1,800 health fairs in local communities where they “Our purpose at WBA is to help provided u clinics, diabetes screening and information on opioid safety and drug takeback people live healthier and happier during scal year ending August 31, 2019. (Photo: Business Wire) lives,” said Ornella Barra, WBA’s co-chief operating ocer and the chairman of the company’s Corporate Social Responsibility Committee. “Everyone deserves the opportunity to fulll his or her potential, regardless of where one lives. That’s why we mobilize our incredible employees and invest resources in issues that impact our patients, customers and society. We believe in our ability to eect positive change in communities around the world.” WBA is a leading global pharmacy retailer and wholesaler, present in 25 countries, including equity method investments. The company includes Boots UK, Boots Ireland, Alliance Healthcare and Walgreens and reaches millions of customers and patients through its retail pharmacy businesses every day. Highlights from this year’s report include: Expansion of In-Store Support for People Living with Cancer For the past 20 years, Walgreens Boots Alliance and its businesses has sought to create innovative and meaningful support for cancer patients and their loved ones. For more than 10 years, Boots UK and Macmillan Cancer Support, one of the largest British charities, have worked together to train beauty consultants and pharmacists to deliver in-store advice to patients and customers on managing physical and emotional side eects of cancer and cancer treatments. Following the UK in-store model, in March 2019, Walgreens launched Feel More Like You™ which also positions trained beauty consultants and pharmacists to advise and support people with cancer at more than 3,000 U.S. locations. “The experience of cancer can be incredibly lonely,” said Jonathan, a cancer survivor. “Being able to talk with a Boots pharmacist who understood what I was going through and could give me advice on how to manage my physical and emotional side eects helped me feel less lonely and gave me the condence to tackle my diagnosis head on.” Life-Changing Vitamins to More Than 200 Million Women and Children In addition to addressing cancer, WBA has also dedicated eorts to improving healthcare in communities around the world. Six years ago, Walgreens and nonprot Vitamin Angels teamed up to improve maternal and child health around the world. To date, the partners have provided vitamins to more than 200 million women and children around the world. The charitable partnership works in two ways: For every customer purchase of vitamins from select suppliers, Walgreens donates one percent of sales to Vitamin Angels’ outreach eorts across the U.S. and globally. Additionally, for the past two years, Walgreens ‘Quarter Drive’ customer donation campaign in January has raised more than $3 million for the Vitamin Angels’ mission. “You cannot underestimate the impact of Walgreens partnership with Vitamin Angels,” said Dr. Nikhil Harikrishnan, MPH, Vitamin Angels program manager in Asia. “I have seen rst-hand what a small intervention like a prenatal vitamin or vitamin A can do. We are literally changing lives, and that’s why the 200 million women and children impacted by our partnership is so incredible.” Waste Reduction and First-of-its-Kind Sustainable Shopping Experience The new CSR report also details eorts across WBA businesses to reduce energy consumption, cut the amount of waste that goes to landll and empower employees and customers to adopt environmentally friendly actions. In July 2019, Boots UK launched its agship Covent Garden store, a rst-of-its-kind retail environment. The store features a water station where customers can rell their reusable water bottles and a relling station for products such as shampoo. All Boots UK stores are also eliminating single-use plastic bags in favor of unbleached paper bags, a continuation of Boots journey to reduce plastic use across its business. “In building the Covent Garden store, we wanted to design the Boots retail experience of the future, one built with sustainability front of mind,” said Sebastian James, managing director of Boots UK and Republic of Ireland. “As a global business, we view sustainability holistically, from our supply chain to the in-store experience we deliver for customers. It’s all connected to our desire to operate as a responsible and best-in-class company.” The WBA 2019 CSR Report was prepared in accordance with the GRI Standards: Core option, which are the world’s most widely used set of sustainability reporting standards. You can read more about WBA’s Corporate Social Responsibility eortshere. About Walgreens Boots Alliance (WBA) Walgreens Boots Alliance (Nasdaq: WBA) is a global leader in retail and wholesale pharmacy, touching millions of lives every day through dispensing and distributing medicines, its convenient retail locations, digital platforms and health and beauty products. The company has more than 100 years of trusted health care heritage and innovation in community pharmacy and pharmaceutical wholesaling. Including equity method investments, WBA has a presence in more than 25 countries, employs more than 440,000 people and has more than 18,750 stores. WBA’s purpose is to help people across the world lead healthier and happier lives. The company is proud of its contributions to healthy communities, a healthy planet, an inclusive workplace and a sustainable marketplace. The company’s businesses have been recognized for their Corporate Social Responsibility. Walgreens was named to FORTUNE* magazine’s 2019 Companies that Change the World list and Boots UK was recognized as Responsible Business of the Year 2019-2020 by Business in the Community. WBA is included in FORTUNE’s 2020 list of the World’s Most Admired Companies. This is the 27th consecutive year that WBA or its predecessor company, Walgreen Co., has been named to the list. More company information is available at www.walgreensbootsalliance.com. *© 2019, Fortune Media IP Limited. Used under license. (WBA-GEN) Cautionary Note Regarding Forward-Looking Statements: All statements in this release and related CSR report that are not historical, including program goals, the expected execution and eect of our Corporate Social Responsibility strategies and initiatives and the amounts and timing of their expected impact, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward- looking statements are not guarantees of future performance and involve risks, assumptions and uncertainties, known or unknown, including those described in Item 1A (Risk Factors) of Walgreens Boots Alliance’s Form 10-K for the scal year that ended August 31, 2019 and in other documents that Walgreens Boots Alliance les or furnishes with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially. These forward-looking statements speak only as of the date they are made. Except to the extent required by law, Walgreens Boots Alliance does not undertake, and expressly disclaims, any duty or obligation to update publicly any forward-looking statement after the date of this release, whether as a result of new information, future events, changes in assumptions or otherwise. View source version on businesswire.com: https://www.businesswire.com/news/home/20200211005125/en/ Media Relations USA / Pamela Morris [email protected] +1 224 419 0375 Investor Relations Gerald Gradwell and Jay Spitzer +1 847 315 2922 Source: Walgreens Boots Alliance.
Recommended publications
  • News: Interview with Ornella Barra on Forbes Monaco
    THE NEXT BILLION DOLLAR SAFARI BUSINESS BILLION- A CASE FOR MONACO’S EU DEAL DOLLAR STARTUPS TRUMP UNCONSTRAINED THE $6 BILLION WEATHER WARS “I’ve always had an entrepreneurial mindset and curious att itude. This empowered me to envision pharmacy’s full potential.” SPECIAL ENTREPRENEURIAL WOMEN Over the Counter with Ornella Barra HOW THE COMMUNITY PHARMACIST TURNED M 31766 5 F : €9 RD DRUGSTORE MOGUL IS 00030 BREAKING THE GLASS 9.50 CEILING. 3 783176 609006 Benelux: AUGUST 2019 MONACO FEMALE ENTREPRENEURS THE PROFILE 42 43 RANKED LAST YEAR AS ONE OF THE MOST POWERFUL WOMEN IN BUSINESS OUTSIDE THE U.S., PHARMACIST ORNELLA BARRA FOUNDED A WHOLESALE BUSINESS IN 1984 THAT TWO YEARS LATER BECAME ITALY’S LEADING DRUG DISTRIBUTOR WHEN IT MERGED WITH ALLEANZA SALUTE ITALIA, HEADED BY STEFANO PESSINA. THE COUPLE’S GREAT CHEMISTRY HAS ENDURED OVER 35 YEARS AND BARRA IS NOW CO-COO OF THE WORLD’S LARGEST DRUGSTORE CHAIN, WALGREENS BOOTS ALLIANCE. OTHESE BOOTS ARE MADE FOR WALGREENS BY CELINA LAFUENTE DE LAVOTHA PHOTOTGRAPH BY THIERRY BEAUVILAIN OUVRARD AUGUST 2 019 FORBES MONACO ambitious drive, she knew her career options would be arra stepped into her co-COO role in today and we are right in the middle of this evolution. limited. She instead studied Pharmacy at the University of June 2016 and oversees Global Brands, The nature of medicines is changing, as we see with Genoa, then managed a local pharmacy before acquiring B Pharmaceutical Wholesale, the Retail the growing importance of pharmacogenetics [the one in her hometown in 1979. “I always wanted to build Pharmacy International businesses outside study of the role of the genome in drug response].” something important for myself and others.
    [Show full text]
  • Leading by Example Stefano Pessina Won the 2013 Clarity Search Retail Leader of the Year Award
    Sponsored by THE CLARITY SEARCH RETAIL LEADER OF THE YEAR Leading by example Stefano Pessina won the 2013 Clarity Search Retail Leader of the Year award. Tiffany Holland talks to the Alliance Boots executive chairman to find out why he’s ahead of the pack n first meeting, it’s easy Last year the self-made billionaire to guess that Stefano revealed that Alliance Boots would Pessina is an entrepre- be partnering with US drugstore Oneur. He wears the sort of chain Walgreens, which will even- sharp suits you’d expect of a billion- tually lead to a full merger. aire and his confident, composed It was one of the most remarkable air could calm any boardroom. business moves in years, as Alliance As the boss of Alliance Boots, Boots, which earned a trading profit one of the largest retailers in the UK of £1.2bn in the last financial year, and one of the biggest pharmaceuti- joined forces with Walgreens’ cal wholesalers in the world, he is empire of 8,000 stores. known for his serene demeanour – The US retailer generated an oper- something that was undoubtedly ating income of $3.5bn (£2.3bn) in useful last June when he brokered the same financial year. In June it the landmark retail deal of 2012. was revealed that Walgreens would But when Retail Week speaks to initially invest $6.7bn (£4.5bn) in him, the Italian businessman is in cash and stocks to acquire 45% high spirits, cracking jokes and equity in Alliance Boots, with a revelling in the recognition his view to merge within three years.
    [Show full text]
  • Give Me More! the New Marketing Mantra in Hair Care
    AN ISSUE OF WOMEN’S WEAR DAILY THE BUSINESS OF BEAUTY HOLLYWOOD’S RED CARPET WHIZ KIDS INFOMERCIAL-MANIA DOLLAR STORES CASH IN GIVE ME MORE! THE NEW MARKETING MANTRA IN HAIR CARE %%3*;&29(5DLQGG 30 $QQSPWFEXJUIXBSOJOHT WWD BEAUTY INC 3 FEATURES 26 Small Screen Dreams The infomercial channel is booming as established players look to solidify their CONTENTS position amidst an onslaught of new entrants. 30 Maximum Volume Hair-care marketers are aiming to transform the way women approach hair-care regimens—and pump up sales to boot. 36 Penny Press As one of the fastest-growing channels in retail, the value-oriented dollar stores are now also the most competitive. 40 Red Carpet Whiz Kids Hollywood’s hottest young hair stylists and makeup artists. DEPARTMENTS CORNER OFFICE 8 The Laugh Master Under Aurelian Lis, Benefit’s humorous ethos has flourished, but the brand’s explosive growth in North America is no joke. 10 Black Book: Brooke Wall The super-chic founder of The Wall Group shares her favorite L.A. haunts. 11 My First Job: Jerrod Blandino Getting creative at Chuck E. Cheese. BEAUTY BULLETIN 14 Pop Rocks Spring’s bright color palette. 16 Launch Window Key products hitting stores now. 18 Singular Sensations Inspired looks from the European runways. CONSUMER CHRONICLES 20 Tinseltown’s Newest Beauty Destination Testing the waters at Hollywood’s swanky new Walgreens. 24 Shopper Stalker Who’s buying what—and why– on Manhattan’s Upper West Side. MISC 6 Pete Unplugged Pete Born, WWD’s executive editor of beauty, surveys the global indie beauty scene.
    [Show full text]
  • EPF Newsletter European Pharmacists Forum Newsletter – English Edition July 2019 Issue 55
    EPF Newsletter European Pharmacists Forum Newsletter – English edition July 2019 Issue 55 Twenty years of progress Ornella Barra, Co-Chief Operating Officer, Walgreens Boots Alliance, looks back at 20 years of progress for the European Pharmacists Forum sharing how it has evolved over the years to become a leading voice for independent pharmacy… The concept of EPF began when Alliance with the Boots Group and this brought Santé merged with Unichem in 1997 to EPF further opportunities to explore form Alliance Unichem, becoming one of expertise and best practice in healthcare the largest pan-European leaders across and beauty services, to complement the wholesale and retail. With such expertise existing independent pharmacy offer. and economies of scale, how could an independent pharmacist be able to My dear friend, Mike Smith, who is also capitalise on this and ensure they could the EPF’s inaugural President and current be part of the healthcare evolution? Who priority was primarily the dispensing of Chair of the EPF’s Stakeholder Group, would champion their voice? prescription medicines. However, with recently reflected on an early example increasing pressures on margins, many of how the EPF is at the forefront of For those who know me, pharmacy were asking how they could add value innovation in pharmacy. He shared with is in my DNA and I’m a passionate to their business. Through the EPF, we me, “In the late 90s, we held a Forum ambassador of pharmacy being at the were able to leverage the expertise of where there was a focussed discussion heart of healthcare.
    [Show full text]
  • HEALTH + Registered Offi Ce Helping People Look Alliance Boots Gmbh and Feel Their Best Baarerstrasse 94 CH-6300 Zug Switzerland
    Alliance Boots Boots Alliance Annual Report 2010/11 Annual For more information www.allianceboots.com HEALTH + Registered offi ce Helping people look Alliance Boots GmbH and feel their best Baarerstrasse 94 CH-6300 Zug Switzerland Contact [email protected] Alliance Boots Annual Report 2010/11 Overview Our performance in 2010/11 Glossary of key terms (for the year ended 31 March 2011) Constant currency Like for like revenue Trading profit Exchange rates applicable for the financial Like for like revenue on a constant currency basis Profit from operations before amortisation of information for the year ended 31 March 2010. compared to the comparable period in the customer relationships and brands, exceptional previous year. items and share of post tax earnings of EBITDA associates and joint ventures. Trading profit before underlying depreciation Net borrowings Revenue EBITDA Trading profit and amortisation. Cash and cash equivalents, restricted cash, Underlying depreciation and amortisation derivative financial instruments and borrowings Depreciation and amortisation adjusted to Exceptional items net of unamortised prepaid financing fees. exclude amortisation of customer relationships Items classified by Alliance Boots as exceptional and brands and depreciation and amortisation in nature. These are not regarded as forming Net finance costs within exceptional items. +15.1% +10 . 8 % +14 . 2 % part of the underlying trading activities of the Finance costs net of finance income. Group and so merit separate presentation to Underlying net finance costs allow stakeholders to understand the elements Restricted cash Net finance costs adjusted to exclude of financial performance and assess trends in Cash which is restricted for specific purposes exceptional items and timing differences within financial performance.
    [Show full text]
  • Carissimi Tutti
    Email di Annuncio – Eccezionalmente la SCUOLA approda al Forum Virtuale Women4Women - Mercoledì 12 maggio h.17:00 News del 6 Maggio 2021 Carissimi tutti, con una certa emozione e profondo senso di gratitudine voglio condividere con voi l’invito a partecipare al Forum Virtuale Women4Women - mercoledì 12 maggio h.17.00, augurandomi che siate in tanti ad aderirvi. Grazie al dott. Alfredo Ambrosetti ho avuto modo di conoscere la dott.ssa Ornella Barra, entrambi persone di grande umiltà, veri giganti al servizio della Nazione. La dott.ssa Ornella Barra, genovese di nascita, laurea in Farmacia, è oggi Chief Operating Officer, International di Walgreens Boots Alliance, a capo, col compagno di vita e di lavoro Stefano Pessina, di una realtà presente dal Nord al Sudamerica, dall’Europa alla Cina. Un gruppo che ha il suo quartier generale a Chicago, gli uffici a Londra; lo stile di Ornella è, comunque, rimasto, virtualmente, genovese. Una delle donne più influenti al mondo, come riviste di settore l'hanno definita, che ha mantenuto un’estrema riservatezza nei modi e nello stile di vita. Vale la pena citare le sue parole: «Sono cresciuta in una famiglia di imprenditori. Mio padre e mia madre hanno sempre avuto una dedizione molto forte per il lavoro e per la famiglia. Grazie al loro esempio, ho sempre saputo che nella vita bisogna impegnarsi e spesso anche sacrificarsi. Ma non è solo senso del dovere quello che mi è stato trasmesso. Certo, è un elemento importante per la formazione di un giovane, donna o uomo che sia… Ma quello che conta davvero, e che nella mia educazione ho avuto la fortuna di ricevere, è lo spirito di iniziativa.
    [Show full text]
  • US Approves OTC Differin in First Retinoid Drug Switch
    OTC22-07-2016p1_OTC15/11/2005 p1&24 19/07/2016 12:57 Page 1 22 July 2016 COMPANY NEWS 2 US approves OTC Differin Moberg buys three brands 2 from Prestige J&J takes 19.9% stake 3 in Japan’s Ci:z Holdings in first retinoiddrugswitch WBA to enter South Korea 4 with Emart cne sufferers in the US will soon be able Taisho takes DHG stake 5 Ato buyGalderma’sadapalene-based to aid its expansion plans Differin Gel 0.1% without aprescription, Alibaba grabs Chinese pharmacy chain 6 after the Food and Drug Administration Japan’s Suntorypicks up 7 (FDA)approvedthe product for OTC sale. GSK’s drinks in Nigeria Differin is the first retinoid-based product Alphrema purchase grows 8 to be made available OTCfor the treatment of Urgo’s presence in Italy acne in the US, with adapalene the first new Pharmacy2U agrees merger 8 ingredient for treating acne to be switched in the country since the 1980s. The product has Differin Gel 0.1% is the first retinoid-based product to GENERAL NEWS 9 been approvedfor the OTCtreatment of acne be available OTC in the US vulgaris in people aged 12 years or older. vations to enhance skin health,”hesaid. German experts against 9 Miles Harrison, president and general man- Commenting on the switch, LesleyFurlong, switching metronidazole ager of Galderma, claimed that the switch would deputy director of the FDA’sOffice of New PRACopens safetyreview 10 be a“game-changer for consumers and the acne Drugs IV,said that millions of consumers, of modified paracetamol category”, butdid not give alaunch date for from adolescents to adults, would nowhave BAH wants EMA to move to Bonn 10 the OTCproduct.
    [Show full text]
  • Vote Summary Report
    Please see last page for important disclosure Vote Summary Report Reporting Period: 07/01/2018 to 06/30/2019 BT Group plc Meeting Date: 07/11/2018 Proposal Vote Number Proposal Text Instruction Meeting for ADR Holders 1 Accept Financial Statements and Statutory For Reports 2 Approve Remuneration Report Against 3 Approve Final Dividend For 4 Elect Jan du Plessis as Director Against 5 Re-elect Gavin Patterson as Director Against 6 Re-elect Simon Lowth as Director Against 7 Re-elect Iain Conn as Director Against 8 Re-elect Tim Hottges as Director Against 9 Re-elect Isabel Hudson as Director Against 10 Re-elect Mike Inglis as Director Against 11 Re-elect Nick Rose as Director Against 12 Re-elect Jasmine Whitbread as Director Against 13 Appoint KPMG LLP as Auditors For 14 Authorise Board to Fix Remuneration of For Auditors 15 Authorise Issue of Equity with Pre-emptive For Rights 16 Authorise Issue of Equity without Pre-emptive For Rights 17 Authorise Market Purchase of Ordinary Shares For 18 Authorise the Company to Call General For Meeting with Two Weeks' Notice 19 Authorise EU Political Donations and For Expenditure Steelcase Inc. Meeting Date: 07/11/2018 Please see last page for important disclosure Vote Summary Report Reporting Period: 07/01/2018 to 06/30/2019 Steelcase Inc. Proposal Vote Number Proposal Text Instruction 1a Elect Director Lawrence J. Blanford For 1b Elect Director Timothy C. E. Brown For 1c Elect Director Connie K. Duckworth Against 1d Elect Director David W. Joos For 1e Elect Director James P.
    [Show full text]
  • Introduction Chapter 1
    Notes Introduction 1 This followed on from the Financial Services Authority discussion paper November 2006, which highlighted the risks of growing debt levels (FSA 2006). See conclusion. 2 It cannot for example override common and statute law regarding fraud and does not exempt the fund from investment law, competition law etc. Chapter 1 1 The term tendency is used here within the broad ‘realist’ tradition of social theory. Any given identifiable social entity has causal powers based on its constitution and relations. The operation of those causal powers creates further potentials that may be realised, given circumstances that are conducive, including the inter- action with other social entities. What exactly a social entity is raises the further issue of agency and structure and various problems of structural determinism dichotomised with methodological individualism. The minutiae of social theory debate on these issues are not strictly relevant here, however. See Harre and Madden (1975), Sayer (1982), Pinkstone (2007). 2 The very first, however, appeared in the early 1960s. I am indebted to Fenn, Liang and Prowse’s (1995) extensive study for the Federal Reserve as a main initial source for the early part of this section. The studies bibliography was also particularly useful in tracking down relevant material by various scholars in organisation and finance (Jensen, Kaplan etc.) who took an early interest in the phenomenon. An extended version of the Fenn et al. original study is available in Financial Markets, Institutions and Instruments 6 (4) 1997: 1–106. Gompers and Lerner (2000: 285; 1998: 151–2) also note the creation of the firm American Research and Develop- ment (ARD) in 1946 (See also Cohen 2007: 15).
    [Show full text]
  • Vote Summary Report Date Range Covered: 01/01/2018 to 12/31/2018 Institution Account(S): AFL-CIO Reserve Fund
    Vote Summary Report Date range covered: 01/01/2018 to 12/31/2018 Institution Account(s): AFL-CIO Reserve Fund 3M Company Meeting Date: 05/08/2018 Country: USA Primary Security ID: 88579Y101 Record Date: 03/13/2018 Meeting Type: Annual Primary CUSIP: 88579Y101 Shares Voted: 316 Proposal Vote Number Proposal Text Instruction 1a Elect Director Sondra L. Barbour For Voter Rationale: In voting on nominees for the board of directors, the shareholder examines each nominee to determine if he or she is an independent outsider or an insider (e.g., a key executive, a relative of a key executive, a contractor with the company). It is in the best interests of shareholders for there to be a two-thirds majority of independent outsiders on the board to supervise management. There is such a majority here. A vote is cast for all nominees. 1b Elect Director Thomas 'Tony' K. Brown For 1c Elect Director David B. Dillon For 1d Elect Director Michael L. Eskew For 1e Elect Director Herbert L. Henkel For 1f Elect Director Amy E. Hood For 1g Elect Director Muhtar Kent For 1h Elect Director Edward M. Liddy For 1i Elect Director Gregory R. Page For 1j Elect Director Michael F. Roman For 1k Elect Director Inge G. Thulin For 1l Elect Director Patricia A. Woertz For 2 Ratify PricewaterhouseCoopers LLP as For Auditors Voter Rationale: The appointment of auditors is considered a routine matter that does not impact materially on shareholders, as long as the auditors are not receiving substantial amounts of money from the Company for other services that give rise to a potential conflict of interest.
    [Show full text]
  • United States Securities and Exchange Commission Washington, D.C
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM N-PX ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED MANAGEMENT INVESTMENT COMPANIES INVESTMENT COMPANY ACT FILE NUMBER: 811-4526 NAME OF REGISTRANT: VANGUARD QUANTITATIVE FUNDS ADDRESS OF REGISTRANT: PO BOX 2600, VALLEY FORGE, PA 19482 NAME AND ADDRESS OF AGENT FOR SERVICE: ANNE E. ROBINSON PO BOX 876 VALLEY FORGE, PA 19482 REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: (610) 669-1000 DATE OF FISCAL YEAR END: SEPTEMBER 30 DATE OF REPORTING PERIOD: JULY 1, 2018 - JUNE 30, 2019 FUND: VANGUARD GROWTH AND INCOME FUND --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ISSUER: 1st Source Corp. TICKER: SRCE CUSIP: 336901103 MEETING DATE: 4/18/2019 FOR/AGAINST PROPOSAL: PROPOSED BY VOTED? VOTE CAST MGMT PROPOSAL #1a: ELECT DIRECTOR DANIEL B. FITZPATRICK ISSUER YES FOR FOR PROPOSAL #1b: ELECT DIRECTOR NAJEEB A. KHAN ISSUER YES FOR FOR PROPOSAL #1c: ELECT DIRECTOR CHRISTOPHER J. MURPHY, ISSUER YES FOR FOR IV PROPOSAL #2: RATIFY BKD LLP AS AUDITOR ISSUER YES FOR FOR --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ISSUER: 3D Systems Corporation TICKER: DDD CUSIP: 88554D205 MEETING DATE: 5/21/2019 FOR/AGAINST PROPOSAL: PROPOSED BY VOTED? VOTE CAST MGMT PROPOSAL #1.1: ELECT DIRECTOR MALISSIA CLINTON ISSUER YES FOR FOR PROPOSAL #1.2: ELECT DIRECTOR WILLIAM E. CURRAN ISSUER YES FOR FOR PROPOSAL #1.3: ELECT DIRECTOR THOMAS W. ERICKSON ISSUER YES FOR FOR PROPOSAL #1.4: ELECT DIRECTOR CHARLES W. HULL ISSUER YES FOR FOR PROPOSAL #1.5: ELECT DIRECTOR WILLIAM D. HUMES ISSUER YES FOR FOR PROPOSAL #1.6: ELECT DIRECTOR VYOMESH I. JOSHI ISSUER YES FOR FOR PROPOSAL #1.7: ELECT DIRECTOR JIM D.
    [Show full text]
  • Notice of 2017 Annual Meeting of Stockholders and Proxy Statement
    Notice of 2017 Annual Meeting of Stockholders and Proxy Statement Notice of 2017 AnnualMeeting of Stockholders December 8, 2016 Dear Fellow Stockholders: Youare invitedtoattend the WalgreensBoots Alliance,Inc.2017 AnnualMeeting of Stockholders, which willbeheld on Thursday, January 26,2017,at8:30 a.m., Eastern StandardTime, at Park Hyatt NewYork, 153West 57th Street,New York,New York 10019. Doorswill open at 7:45 a.m. At the meeting, stockholders will be asked to: • Elect the ten director nominees named in the proxy statement; • Approve,onanadvisory basis,the Company’snamed executive officer compensation; • Ratify theappointmentofDeloitte &Touche LLP as the Company’sindependent auditorfor 2017; • Approve thematerialtermsofthe performance measuresunder the Company’s 2011 Cash-Based Incentive Plan; • Vote on thetwo stockholder proposalscontainedinthe proxystatement, if properly presentedatthe meeting;and • Transact such other businessasmay properly comebefore themeetingand any adjournment or postponement thereof. Youare eligible to vote if you wereastockholder of recordasofthe close of business on November 28,2016. Your vote is important. Please vote by Internet, telephone, or mail as soonaspossible to ensureyour vote is recorded promptly.Your vote beforethe annualmeetingwill ensure representation of your shares. Please alsonotethat,beginningthisyear,ifyou want to attendthe annual meetinginperson,you must pre-registerand obtain an admission ticket in advance.Toobtainanadmission ticket, please followthe instructions on page 73 of theproxy
    [Show full text]